Invenomic Capital Management LP lessened its stake in Dun & Bradstreet Holdings, Inc. (NYSE:DNB – Free Report) by 17.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,812,722 shares of the business services provider’s stock after selling 378,078 shares during the period. Dun & Bradstreet makes up approximately 1.1% of Invenomic Capital Management LP’s holdings, making the stock its 21st largest position. Invenomic Capital Management LP’s holdings in Dun & Bradstreet were worth $22,587,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in DNB. Steward Partners Investment Advisory LLC increased its position in Dun & Bradstreet by 7,875.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 32,299 shares of the business services provider’s stock valued at $402,000 after acquiring an additional 31,894 shares during the last quarter. Proficio Capital Partners LLC bought a new position in Dun & Bradstreet in the fourth quarter worth approximately $323,000. Charles Schwab Investment Management Inc. grew its position in shares of Dun & Bradstreet by 2.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,075,848 shares of the business services provider’s stock valued at $50,785,000 after acquiring an additional 99,795 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Dun & Bradstreet by 9.3% in the 4th quarter. Bank of New York Mellon Corp now owns 1,657,713 shares of the business services provider’s stock worth $20,655,000 after purchasing an additional 141,054 shares in the last quarter. Finally, Park Avenue Securities LLC lifted its position in Dun & Bradstreet by 15.5% during the fourth quarter. Park Avenue Securities LLC now owns 60,548 shares of the business services provider’s stock valued at $754,000 after purchasing an additional 8,103 shares in the last quarter. 86.68% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, Chairman William P. Foley II sold 2,500,000 shares of the company’s stock in a transaction dated Tuesday, March 25th. The shares were sold at an average price of $8.99, for a total transaction of $22,475,000.00. Following the sale, the chairman now directly owns 8,109,644 shares in the company, valued at approximately $72,905,699.56. This represents a 23.56 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 10.44% of the company’s stock.
Dun & Bradstreet Price Performance
Dun & Bradstreet (NYSE:DNB – Get Free Report) last posted its earnings results on Thursday, May 1st. The business services provider reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. The company had revenue of $579.80 million for the quarter, compared to the consensus estimate of $578.02 million. Dun & Bradstreet had a positive return on equity of 11.29% and a negative net margin of 1.20%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.20 earnings per share. On average, equities analysts anticipate that Dun & Bradstreet Holdings, Inc. will post 0.96 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of analysts have commented on the company. Royal Bank of Canada restated a “sector perform” rating and issued a $12.00 price target on shares of Dun & Bradstreet in a research report on Wednesday, January 29th. Jefferies Financial Group restated a “hold” rating and set a $9.15 target price (down previously from $11.00) on shares of Dun & Bradstreet in a research note on Tuesday, March 25th. Needham & Company LLC reaffirmed a “hold” rating on shares of Dun & Bradstreet in a report on Friday, May 2nd. StockNews.com began coverage on shares of Dun & Bradstreet in a research note on Monday, May 5th. They issued a “hold” rating for the company. Finally, The Goldman Sachs Group lowered their target price on shares of Dun & Bradstreet from $12.80 to $11.00 and set a “neutral” rating on the stock in a research note on Friday, February 21st. Seven analysts have rated the stock with a hold rating, According to MarketBeat, Dun & Bradstreet has an average rating of “Hold” and an average price target of $11.86.
Check Out Our Latest Stock Analysis on DNB
About Dun & Bradstreet
Dun & Bradstreet Holdings, Inc engages in providing business decisioning data and analytics solutions. The firm is involved in providing information with its solutions to support its clients with critical business operations. It offers end-to-end solutions to clients in the small business, finance, sales & marketing, third party risk & compliance, and public sectors.
See Also
- Five stocks we like better than Dun & Bradstreet
- How to Profit From Value Investing
- Constellation Powers Up With Reinforced AI Data Center Strategy
- How to invest in marijuana stocks in 7 steps
- Top Analyst-Rated Healthcare Stocks to Watch Now
- What Investors Need to Know to Beat the Market
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Want to see what other hedge funds are holding DNB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dun & Bradstreet Holdings, Inc. (NYSE:DNB – Free Report).
Receive News & Ratings for Dun & Bradstreet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dun & Bradstreet and related companies with MarketBeat.com's FREE daily email newsletter.